PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17579786-2	2007	ASMC proliferation was examined by flow cytometry analysis, methyl thiazolyl tetrazolium (MTT) colorimetric assay, [(3)H]-thymidine (TdR) incorporation and proliferating cell nuclear antigen (PCNA) immunocytochemical staining.	asmc	0-4	proliferating cell nuclear antigen	Rattus norvegicus	192-196	
18630259-8	2008	There was significant change of CyclinD1 expression between vector and sense CyclinD1 transfected cells, and the expression level of CyclinD1 in ASMC transfected with antisense CyclinD1 was lower than that in vector transfected cells (P <0.01); (3) In the asthmatic groups, compared with the vecter group, the percentage of S + G2M phase, absorbance A value of MTT and the expression rate of PCNA protein in ASMC transfected with pcDNA3.	asmc	145-149	proliferating cell nuclear antigen	Rattus norvegicus	395-399	
24010863-8	2013	The expression of PCNA and absorbance of MTT assay in asthma rat ASMC was also significantly increased.	asmc	65-69	proliferating cell nuclear antigen	Rattus norvegicus	18-22	
24010863-10	2013	Furthermore, the expression of PCNA and absorbance of MTT assay in asthmatic rat ASMC was significantly reduced after SMI treatment.	asmc	81-85	proliferating cell nuclear antigen	Rattus norvegicus	31-35	
23919305-10	2013	RESULTS: (1) The expression of PCNA was significantly increased in intact asthmatic rat ASMC.	asmc	88-92	proliferating cell nuclear antigen	Rattus norvegicus	31-35